SCHEMBL4650694

SCHEMBL4650694

c1ccc(N(c2cccc3ccccc23)c2c3ccccc3c(N(c3ccccc3)c3cccc4ccccc34)c3ccccc23)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 9/20 0.47
L3MBTL1 Q9Y468 2/20 0.39
CYP1A2 P05177 4/20 0.38
CYP3A4 P08684 3/20 0.38
CYP2D6 P10635 2/20 0.38
CYP2C9 P11712 2/20 0.38
CYP2C19 P33261 2/20 0.38
ALDH1A1 P00352 4/20 0.37
CYP2A6 P11509 3/20 0.37
TSHR P16473 2/20 0.37
HSD17B10 Q99714 2/20 0.37
TDP1 Q9NUW8 2/20 0.37
HPGD P15428 1/20 0.35
KEAP1 Q14145 1/20 0.35
NR4A1 P22736 1/20 0.35
NR4A2 P43354 1/20 0.35
NR4A3 Q92570 1/20 0.35
HPRT1 P00492 1/20 0.34
KDM4E B2RXH2 1/20 0.34
MAPT P10636 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13250570 0.98 SIGMAR1 (0.46) SIGMAR1L3MBTL1CYP1A2CYP3A4CYP2D6
SCHEMBL4921270 0.96 SIGMAR1 (0.45) SIGMAR1L3MBTL1CYP1A2CYP3A4CYP2D6
SCHEMBL981539 0.94 SIGMAR1 (0.44) SIGMAR1L3MBTL1CYP1A2CYP3A4CYP2D6
SCHEMBL30205806 0.94 SIGMAR1 (0.44) SIGMAR1L3MBTL1CYP1A2CYP3A4CYP2D6
SCHEMBL2332208 0.93 SIGMAR1 (0.43) SIGMAR1L3MBTL1CYP1A2CYP3A4CYP2D6
SCHEMBL4894433 0.92 SIGMAR1 (0.44) SIGMAR1L3MBTL1CYP1A2CYP3A4CYP2D6
SCHEMBL13250576 0.91 SIGMAR1 (0.42) SIGMAR1L3MBTL1CYP1A2CYP3A4CYP2D6
SCHEMBL14267100 0.91 SIGMAR1 (0.45) SIGMAR1L3MBTL1CYP1A2CYP3A4CYP2D6
SCHEMBL13250569 0.90 SIGMAR1 (0.42) SIGMAR1L3MBTL1CYP1A2CYP3A4CYP2D6
SCHEMBL272955 0.90 SIGMAR1 (0.51) SIGMAR1L3MBTL1CYP1A2CYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 62 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1966344-A2 AMINO ANTHRACENE COMPOUNDS IN OLED DEVICES Eastman Kodak Company (US) 2008-09-10 EP claimed
WO-2007075286-A2 AMINO ANTHRACENE COMPOUNDS IN OLED DEVICES EASTMAN KODAK COMPANY (US) 2007-07-05 WO claimed
US-20070141393-A1 Amino anthracene compounds in OLED devices EASTMAN KODAK COMPANY 2007-06-21 US claimed
US-11873293-B2 Organic molecules for optoelectronic devices SAMSUNG DISPLAY CO., LTD. (KR) 2024-01-16 US disclosed
US-11873293-B2 Organic molecules for optoelectronic devices SAMSUNG DISPLAY CO., LTD. (KR) 2024-01-16 US disclosed
US-20230354693-A1 SUPERFLUORESCENT CERIUM (III)-CONTAINING CHELATE APPLICABLE TO PHOTOELECTRIC DEVICES AND HAVING A DUAL CAPTURE MECHANISM AND ULTRA-SHORT DECAY TIME SICHUAN KNOWLEDGE EXPRESS INSTITUTE FOR INNOVATIVE TECHNOLOGIES CO., LTD (CN) 2023-11-02 US disclosed
US-20230337538-A1 ORGANIC MOLECULES FOR OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2023-10-19 US disclosed
US-20230337538-A1 ORGANIC MOLECULES FOR OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2023-10-19 US disclosed
US-20230309398-A1 ORGANIC MOLECULES FOR OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2023-09-28 US disclosed
US-20230309398-A1 ORGANIC MOLECULES FOR OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2023-09-28 US disclosed
US-20230292615-A1 ORGANIC MOLECULES FOR OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2023-09-14 US disclosed
US-20100176377-A1 Polymeric compound and polymeric electroluminescence element using the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-07-15 US disclosed
US-20100176377-A1 Polymeric compound and polymeric electroluminescence element using the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-07-15 US disclosed
US-7651788-B2 Organic electroluminescent device LG DISPLAY CO., LTD. (KR) 2010-01-26 US disclosed
US-7651788-B2 Organic electroluminescent device LG DISPLAY CO., LTD. (KR) 2010-01-26 US disclosed
US-7507485-B2 Electrolytic cell; indium tin anode, hole injection layer containing phthalocyanine dye, passivation cathode; red illumination efficiency LG DISPLAY CO., LTD. (KR) 2009-03-24 US disclosed
US-7507485-B2 Electrolytic cell; indium tin anode, hole injection layer containing phthalocyanine dye, passivation cathode; red illumination efficiency LG DISPLAY CO., LTD. (KR) 2009-03-24 US disclosed
EP-1966344-A2 AMINO ANTHRACENE COMPOUNDS IN OLED DEVICES Eastman Kodak Company (US) 2008-09-10 EP disclosed
WO-2007075286-A2 AMINO ANTHRACENE COMPOUNDS IN OLED DEVICES EASTMAN KODAK COMPANY (US) 2007-07-05 WO disclosed
US-20070141393-A1 Amino anthracene compounds in OLED devices EASTMAN KODAK COMPANY 2007-06-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230292615-A1 ORGANIC MOLECULES FOR OPTOELECTRONIC DEVICES OR10J3, SALL4, RBP4 SIGMAR1 1257/4885L3MBTL1 2993/4885CYP1A2 3051/4885
US-20230337538-A1 ORGANIC MOLECULES FOR OPTOELECTRONIC DEVICES OCIAD1, OCIAD2, OR10J3 SIGMAR1 837/4885L3MBTL1 938/4885CYP1A2 2716/4885
US-11873293-B2 Organic molecules for optoelectronic devices XDH, C1S, OR10J3 SIGMAR1 1014/4885L3MBTL1 3200/4885CYP1A2 1532/4885
US-20230354693-A1 SUPERFLUORESCENT CERIUM (III)-CONTAINING CHELATE APPLICABLE TO PHOTOELECTRIC DEVICES AND HAVING A DUAL CAPTURE MECHANISM AND ULTRA-SHORT DECAY TIME OCIAD2, OCIAD1, CASR SIGMAR1 59/4885L3MBTL1 3157/4885CYP1A2 3869/4885
US-20230309398-A1 ORGANIC MOLECULES FOR OPTOELECTRONIC DEVICES RXFP4, OR10J3, RXFP3 SIGMAR1 371/4885L3MBTL1 2082/4885CYP1A2 2672/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.